CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹129 Cr | ₹102 Cr | ₹100 Cr | ₹116 Cr | ₹133 Cr |
What is the latest Long Term Provisions ratio of CIPLA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹129 Cr |
Mar2023 | ₹102 Cr |
Mar2022 | ₹100 Cr |
Mar2021 | ₹116 Cr |
Mar2020 | ₹133 Cr |
How is Long Term Provisions of CIPLA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹129 Cr | 26.53 | |
Mar2023 | ₹102 Cr | 1.94 | |
Mar2022 | ₹100 Cr | -13.73 | |
Mar2021 | ₹116 Cr | -12.83 | |
Mar2020 | ₹133 Cr | - |
Compare Long Term Provisions of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,591.2 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.1% |
0.2% |
-2.1% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses